Now, imagine that I use the re-coded E. coli described in the Lajoie paper instead. I engineer an artificial gene into that E. coli, but as I do so I replace several of the (amino-acid-coding) codons with UAG codons, and express a matching tRNA and aaRS (akin to the pEVOL system that these researchers used). Would I still be able to express this gene in the re-coded C321.?A strain that the paper described (with the pEVOL system active)? Why or why not? Would this be an effective strategy for biocontainment (ie, stopping this gene from escaping into the environment via horizontal gene transfer)? Why or why not?